New Weight Loss Strategies with GLP 1

In episode 32 of The Functional Code, Dr. Addy and Dr. Jace delve into GLP-1 agonists like semaglutide and terzepatide, exploring their roles in weight loss and diabetes management. They discuss the mounting reliance on these medications, citing real-life examples and addressing societal and cultural impacts on health. The podcast also covers the historical adjustments to hypertension markers, the projected rise in obesity and diabetes by 2050, pharmaceutical influences, and strategies for utilizing GLP-1 agonists effectively. Listeners are encouraged to take a proactive role in their health, with insights into potential side effects, complementary strategies like resistance training and adequate protein intake, and the importance of building healthy habits. Dr. Jace Nybo D.C. Dr. Addy Knutson D.C. Guide: 00:00 The Hunger Zombie Incident Intro 01:08 Welcome to the Functional Code 01:37 Introduction to GLP-1 and Weight Loss 03:33 The Obesity Epidemic 06:34 Pharmaceutical Influence and Misleading Practices 09:07 Childhood Obesity and Long-Term Health Risks 17:34 Traditional and Surgical Interventions for Obesity 21:06 The History of Diabetes and Weight Loss Medications 28:31 Understanding GLP-1 Mechanisms 36:11 The Impact of GLP-1 on Health 39:30 Misguided Medical Advice and Patient Preparation 40:42 The Hunger Zombie Phenomenon 41:28 Advancements in Weight Loss Medications 44:07 Long-Term Use and Side Effects 59:27 The Importance of Resistance Training and Protein Intake 01:02:44 Proper Management and Use of Weight Loss Medications 01:06:47 Future Developments and Final Thoughts 01:11:54 Conclusion and Final Remarks Resources: doi.org/10.1136/bmj-2023-078225 doi.org/10.1186/s12933-023-01765-z doi.org/10.1016j.molmet.2020.101102 Instagram: instagram.com/thefunctionalcode/ TicTock: @thefunctionalcode Apple Podcast: podcasts.apple.com/us/podcast/the-functional-code-podcast/id1754585557